Last updated: June 4, 2026
No sufficient, complete, and reliable supply-chain source set is available in the provided context to identify specific manufacturers/suppliers, contract manufacturing organizations, or labeled product supply arrangements for “ciprofloxacin in dextrose 5% in plastic container” with enough precision to support business decisions.
Who supplies “ciprofloxacin in dextrose 5%” IV solutions in plastic containers in the US?
Answer: Not determined from the provided information.
What supplier identities are typically on US labels?
Where data is available, the manufacturer name and address, labeled packager, and distributor appear on US labels. For IV admixtures, the “manufacturer of record” often differs from fill-finish or packaging operations.
Which product attributes drive supplier mapping?
- Strength (commonly 200 mg/100 mL or 400 mg/200 mL depending on listing)
- Container type (plastic bag with infusion administration set)
- Labeled indication (ciprofloxacin IV)
- CGMP site(s) for drug substance and sterile drug product fill
Which companies manufacture ciprofloxacin IV in D5W plastic bags?
Answer: Not determined from the provided information.
What categories of suppliers matter for procurement and contracting?
- Sterile drug product manufacturers (aseptic fill)
- Fill-finish and overwrap/packaging sites
- Source of ciprofloxacin API (active pharmaceutical ingredient)
- D5W container and bag line suppliers (typically component-level, not final drug label)
How does the supplier landscape differ by container size and concentration?
Answer: Not determined from the provided information.
Typical concentration mapping (why it matters)
Procurement lead times and allocation often track the exact NDC tied to:
- Volume (100 mL vs 200 mL)
- Strength presentation
- Container and configuration (bag with specific connector type)
What does the Orange Book and FDA labeling show about manufacturers for this product?
Answer: Not determined from the provided information.
Where FDA data usually helps
- Orange Book lists active ingredients and certain approved products, but it does not always enumerate every sterile manufacturing site.
- SPL (Structured Product Labeling) includes “manufacturer,” “packaged by,” and sometimes distributor details.
How many suppliers exist for ciprofloxacin IV in D5W plastic containers?
Answer: Not determined from the provided information.
What “supplier count” depends on
- Number of labeled NDC holders
- Number of manufacturing sites supporting that NDC
- Multiplicity of distributors and labelers
What generic or authorized versions could change supplier availability?
Answer: Not determined from the provided information.
Paragraph IV and exclusivity do not directly map supply without product-level data
Even if there are multiple ANDA products, supplier availability is driven by:
- Which NDCs are actively marketed
- Current manufacturing capacity
- Distribution contracts
- Quality system and inspection outcomes
When do supply constraints typically trigger alternative sourcing for this product?
Answer: Not determined from the provided information.
Trigger signals used in pharma supply risk tracking
- FDA drug shortages database entries
- Lot-level recalls or CGMP enforcement actions
- Allocation notices from distributors
What manufacturing/IP barriers affect substitute sourcing for ciprofloxacin in D5W plastic containers?
Answer: Not determined from the provided information.
What matters for IV sterile liquids
- Aseptic fill capability and sterile barrier technology
- Container compatibility and leachables/extractables qualification
- Stability and shelf-life validation for D5W in the specific plastic system
Key Takeaways
No defensible supplier list can be produced from the provided context. A supplier mapping requires product-level FDA label/manufacturer data and/or verified commercial supply-chain sources.
FAQs
- How do I identify the manufacturer of record for ciprofloxacin in D5W plastic bags by NDC?
- Does the same supplier make both 100 mL and 200 mL plastic bag presentations of ciprofloxacin D5W?
- What sources best identify shortages or allocation for ciprofloxacin IV D5W?
- How do recalls affect which lot-supplying sites are available for ciprofloxacin IV D5W?
- What differences exist between NDC holders, labelers, and actual sterile fill-finish sites for IV ciprofloxacin solutions?
References
No sources were cited because no source data was provided in the prompt.
